| Authors: |
Siurala M; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Vähä-Koskela M; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Havunen R; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Tähtinen S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Bramante S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Parviainen S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Mathis JM; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University , Baton Rouge, LA, USA., Kanerva A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital (HUCH), Helsinki, Finland., Hemminki A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. |
